Will banning drug reps bankrupt caterers?

Daniel Carlat: “From his point of view, it is $40 million lost from the pockets of a niche food business. But from the consumer’s point of view it reminds us of the enormous scale of the pharmaceutical marketing endeavor. The drug industry was once considered an important engine of research and development. But the dirty little secret is that pharmaceutical companies spend more on promotion than on research–much more.”